{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T05:55:54Z","timestamp":1769838954478,"version":"3.49.0"},"reference-count":70,"publisher":"Pharmaceutical Society of Japan","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2019,7,1]]},"DOI":"10.1248\/bpb.b19-00177","type":"journal-article","created":{"date-parts":[[2019,6,30]],"date-time":"2019-06-30T22:03:27Z","timestamp":1561932207000},"page":"1236-1242","source":"Crossref","is-referenced-by-count":20,"title":["Direct Impairment of the Endothelial Function by Acute Indoxyl Sulfate through Declined Nitric Oxide and Not Endothelium-Derived Hyperpolarizing Factor or Vasodilator Prostaglandins in the Rat Superior Mesenteric Artery"],"prefix":"10.1248","volume":"42","author":[{"given":"Takayuki","family":"Matsumoto","sequence":"first","affiliation":[{"name":"Department of Physiology and Morphology, Institute of Medicinal Chemistry, Hoshi University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Takayanagi","sequence":"additional","affiliation":[{"name":"Department of Physiology and Morphology, Institute of Medicinal Chemistry, Hoshi University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihoka","family":"Kojima","sequence":"additional","affiliation":[{"name":"Department of Physiology and Morphology, Institute of Medicinal Chemistry, Hoshi University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoki","family":"Katome","sequence":"additional","affiliation":[{"name":"Department of Physiology and Morphology, Institute of Medicinal Chemistry, Hoshi University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kumiko","family":"Taguchi","sequence":"additional","affiliation":[{"name":"Department of Physiology and Morphology, Institute of Medicinal Chemistry, Hoshi University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuneo","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Physiology and Morphology, Institute of Medicinal Chemistry, Hoshi University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","unstructured":"1) Vanhoutte PM, Zhao Y, Xu A, Leung SW. Thirty years of saying NO: sources, fate, actions, and misfortunes of the endothelium-derived vasodilator mediator. <i>Circ. Res.<\/i>, <b>119<\/b>, 375\u2013396 (2016)."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Vanhoutte PM, Shimokawa H, Feletou M, Tang EH. Endothelial dysfunction and vascular disease\u2014a 30th anniversary update. <i>Acta Physiol.<\/i>, <b>219<\/b>, 22\u201396 (2017).","DOI":"10.1111\/apha.12646"},{"key":"3","unstructured":"3) F\u00e9l\u00e9tou M, Vanhoutte PM. Endothelium-derived hyperpolarizing factor: where are we now? <i>Arterioscler. Thromb. Vasc. Biol.<\/i>, <b>26<\/b>, 1215\u20131225 (2006)."},{"key":"4","unstructured":"4) F\u00e9l\u00e9tou M, Huang Y, Vanhoutte PM. Endothelium-mediated control of vascular tone: COX-1 and COX-2 products. <i>Br. J. Pharmacol.<\/i>, <b>164<\/b>, 894\u2013912 (2011)."},{"key":"5","unstructured":"5) Matsumoto T, Goulopoulou S, Taguchi K, Tostes RC, Kobayashi T. Constrictor prostanoids and uridine adenosine tetraphosphate: vascular mediators and therapeutic targets in hypertension and diabetes. <i>Br. J. Pharmacol.<\/i>, <b>172<\/b>, 3980\u20134001 (2015)."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Matsumoto T, Nakayama N, Ishida K, Kobayashi T, Kamata K. Eicosapentaenoic acid improves imbalance between vasodilator and vasoconstrictor actions of endothelium-derived factors in mesenteric arteries from rats at chronic stage of type 2 diabetes. <i>J. Pharmacol. Exp. Ther.<\/i>, <b>329<\/b>, 324\u2013334 (2009).","DOI":"10.1124\/jpet.108.148718"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Jourde-Chiche N, Dou L, Cerini C, Dignat-George F, Brunet P. Vascular incompetence in dialysis patients\u2014protein-bound uremic toxins and endothelial dysfunction. <i>Semin. Dial.<\/i>, <b>24<\/b>, 327\u2013337 (2011).","DOI":"10.1111\/j.1525-139X.2011.00925.x"},{"key":"8","unstructured":"8) Pereira CA, Carneiro FS, Matsumoto T, Tostes RC. Bonus effects of antidiabetic drugs: possible beneficial effects on endothelial dysfunction, vascular inflammation and atherosclerosis. <i>Basic Clin. Pharmacol. Toxicol.<\/i>, <b>123<\/b>, 523\u2013538 (2018)."},{"key":"9","unstructured":"9) Ravarotto V, Simioni F, Pagnin E, Davis PA, Calo LA. Oxidative stress\u2013chronic kidney disease\u2013cardiovascular disease: a vicious circle. <i>Life Sci.<\/i>, <b>210<\/b>, 125\u2013131 (2018)."},{"key":"10","unstructured":"10) Zhao Y, Vanhoutte PM, Leung SW. Vascular nitric oxide: beyond eNOS. <i>J. Pharmacol. Sci.<\/i>, <b>129<\/b>, 83\u201394 (2015)."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Cahill PA, Redmond EM. Vascular endothelium\u2013gatekeeper of vessel health. <i>Atherosclerosis<\/i>, <b>248<\/b>, 97\u2013109 (2016).","DOI":"10.1016\/j.atherosclerosis.2016.03.007"},{"key":"12","unstructured":"12) Vanhoutte PM. Nitric oxide: from good to bad. <i>Ann. Vasc. Dis.<\/i>, <b>11<\/b>, 41\u201351 (2018)."},{"key":"13","unstructured":"13) Moncada S, Higgs EA. Endogenous nitric oxide: physiology, pathology and clinical relevance. <i>Eur. J. Clin. Invest.<\/i>, <b>21<\/b>, 361\u2013374 (1991)."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Siragusa M, Fleming I. The eNOS signalosome and its link to endothelial dysfunction. <i>Pflugers Arch.<\/i>, <b>468<\/b>, 1125\u20131137 (2016).","DOI":"10.1007\/s00424-016-1839-0"},{"key":"15","unstructured":"15) Garcia V, Sessa WC. Endothelial NOS: perspective and recent developments. <i>Br. J. Pharmacol.<\/i>, <b>176<\/b>, 189\u2013196 (2019)."},{"key":"16","unstructured":"16) Flammer AJ, Luscher TF. Human endothelial dysfunction: EDRFs. <i>Pflugers Arch.<\/i>, <b>459<\/b>, 1005\u20131013 (2010)."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Okahara K, Sun B, Kambayashi J. Upregulation of prostacyclin synthesis-related gene expression by shear stress in vascular endothelial cells. <i>Arterioscler. Thromb. Vasc. Biol.<\/i>, <b>18<\/b>, 1922\u20131926 (1998).","DOI":"10.1161\/01.ATV.18.12.1922"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Shimokawa H, Flavahan NA, Lorenz RR, Vanhoutte PM. Prostacyclin releases endothelium-derived relaxing factor and potentiates its action in coronary arteries of the pig. <i>Br. J. Pharmacol.<\/i>, <b>95<\/b>, 1197\u20131203 (1988).","DOI":"10.1111\/j.1476-5381.1988.tb11756.x"},{"key":"19","unstructured":"19) F\u00e9l\u00e9tou M, Verbeuren TJ, Vanhoutte PM. Endothelium-dependent contractions in SHR: a tale of prostanoid TP and IP receptors. <i>Br. J. Pharmacol.<\/i>, <b>156<\/b>, 563\u2013574 (2009)."},{"key":"20","unstructured":"20) Gluais P, Lonchampt M, Morrow JD, Vanhoutte PM, Feletou M. Acetylcholine-induced endothelium-dependent contractions in the SHR aorta: the Janus face of prostacyclin. <i>Br. J. Pharmacol.<\/i>, <b>146<\/b>, 834\u2013845 (2005)."},{"key":"21","unstructured":"21) Wong MS, Vanhoutte PM. COX-mediated endothelium-dependent contractions: from the past to recent discoveries. <i>Acta Pharmacol. Sin.<\/i>, <b>31<\/b>, 1095\u20131102 (2010)."},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Liu D, Liu B, Luo W, Li H, Zhang Y, Zhou Y. A vasoconstrictor response to COX-1-mediated prostacyclin synthesis in young rat renal arteries that increases in prehypertensive conditions. <i>Am. J. Physiol. Heart Circ. Physiol.<\/i>, <b>309<\/b>, H804\u2013H811 (2015).","DOI":"10.1152\/ajpheart.00150.2015"},{"key":"23","unstructured":"23) Jia G, Durante W, Sowers JR. Endothelium-derived hyperpolarizing factors: a potential therapeutic target for vascular dysfunction in obesity and insulin resistance. <i>Diabetes<\/i>, <b>65<\/b>, 2118\u20132120 (2016)."},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Endo K, Abiru T, Machida H, Kasuya Y, Kamata K. Endothelium-derived hyperpolarizing factor does not contribute to the decrease in endothelium-dependent relaxation in the aorta of streptozotocin-induced diabetic rats. <i>Gen. Pharmacol.<\/i>, <b>26<\/b>, 149\u2013153 (1995).","DOI":"10.1016\/0306-3623(94)00159-K"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Shimokawa H, Yasutake H, Fujii K, Owada MK, Nakaike R, Fukumoto Y, Takayanagi T, Nagao T, Egashira K, Fujishima M, Takeshita A. The importance of the hyperpolarizing mechanism increases as the vessel size decreases in endothelium-dependent relaxations in rat mesenteric circulation. <i>J. Cardiovasc. Pharmacol.<\/i>, <b>28<\/b>, 703\u2013711 (1996).","DOI":"10.1097\/00005344-199611000-00014"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Godo S, Sawada A, Saito H, Ikeda S, Enkhjargal B, Suzuki K, Tanaka S, Shimokawa H. Disruption of physiological balance between nitric oxide and endothelium-derived hyperpolarization impairs cardiovascular homeostasis in mice. <i>Arterioscler. Thromb. Vasc. Biol.<\/i>, <b>36<\/b>, 97\u2013107 (2016).","DOI":"10.1161\/ATVBAHA.115.306499"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Takaki A, Morikawa K, Tsutsui M, Murayama Y, Tekes E, Yamagishi H, Ohashi J, Yada T, Yanagihara N, Shimokawa H. Crucial role of nitric oxide synthase system in endothelium-dependent hyperpolarization in mice. <i>J. Exp. Med.<\/i>, <b>205<\/b>, 2053\u20132063 (2008).","DOI":"10.1084\/jem.20080106"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Ozkor MA, Quyyumi AA. Endothelium-derived hyperpolarizing factor and vascular function. <i>Cardiol. Res. Pract.<\/i>, <b>2011<\/b>, 156146 (2011).","DOI":"10.4061\/2011\/156146"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Coleman HA, Tare M, Parkington HC. Endothelial potassium channels, endothelium-dependent hyperpolarization and the regulation of vascular tone in health and disease. <i>Clin. Exp. Pharmacol. Physiol.<\/i>, <b>31<\/b>, 641\u2013649 (2004).","DOI":"10.1111\/j.1440-1681.2004.04053.x"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) F\u00e9l\u00e9tou M. Endothelium-dependent hyperpolarization and endothelial dysfunction. <i>J. Cardiovasc. Pharmacol.<\/i>, <b>67<\/b>, 373\u2013387 (2016).","DOI":"10.1097\/FJC.0000000000000346"},{"key":"31","unstructured":"31) Garland CJ, Dora KA. EDH: endothelium-dependent hypepolarization and microvascular signalling. <i>Acta Physiol.<\/i>, <b>219<\/b>, 152\u2013161 (2017)."},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) de Wit C, Griffith TM. Connexins and gap junctions in the EDHF phenomenon and conducted vasomotor responses. <i>Pflugers Arch.<\/i>, <b>459<\/b>, 897\u2013914 (2010).","DOI":"10.1007\/s00424-010-0830-4"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Griffith TM. Endothelium-dependent smooth muscle hyperpolarization: do gap junctions provide a unifying hypothesis? <i>Br. J. Pharmacol.<\/i>, <b>141<\/b>, 881\u2013903 (2004).","DOI":"10.1038\/sj.bjp.0705698"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Urakami-Harasawa L, Shimokawa H, Nakashima M, Egashira K, Takeshita A. Importance of endothelium-derived hyperpolarizing factor in human arteries. <i>J. Clin. Invest.<\/i>, <b>100<\/b>, 2793\u20132799 (1997).","DOI":"10.1172\/JCI119826"},{"key":"35","unstructured":"35) Mudrovcic N, Arefin S, Van Craenenbroeck AH, Kublickiene K. Endothelial maintenance in health and disease: importance of sex differences. <i>Pharmacol. Res.<\/i>, <b>119<\/b>, 48\u201360 (2017)."},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Addi T, Dou L, Burtey S. Tryptophan-derived uremic toxins and thrombosis in chronic kidney disease. <i>Toxins<\/i>, <b>10<\/b>, 412 (2018).","DOI":"10.3390\/toxins10100412"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Liu WC, Tomino Y, Lu KC. Impacts of indoxyl sulfate and <i>p<\/i>-cresol sulfate on chronic kidney disease and mitigating effects of AST-120. <i>Toxins<\/i>, <b>10<\/b>, 367 (2018).","DOI":"10.3390\/toxins10090367"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Velasquez MT, Centron P, Barrows I, Dwivedi R, Raj DS. Gut microbiota and cardiovascular uremic toxicities. <i>Toxins<\/i>, <b>10<\/b>, 287 (2018).","DOI":"10.3390\/toxins10070287"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) De Vriese AS, Blom HJ, Heil SG, Mortier S, Kluijtmans LA, Van de Voorde J, Lameire NH. Endothelium-derived hyperpolarizing factor-mediated renal vasodilatory response is impaired during acute and chronic hyperhomocysteinemia. <i>Circulation<\/i>, <b>109<\/b>, 2331\u20132336 (2004).","DOI":"10.1161\/01.CIR.0000129138.08493.4D"},{"key":"40","unstructured":"40) Heil SG, De Vriese AS, Kluijtmans LA, Mortier S, Den Heijer M, Blom HJ. The role of hyperhomocysteinemia in nitric oxide (NO) and endothelium-derived hyperpolarizing factor (EDHF)-mediated vasodilatation. <i>Cell. Mol. Biol.<\/i>, <b>50<\/b>, 911\u2013916 (2004)."},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Cheng Z, Jiang X, Kruger WD, Pratico D, Gupta S, Mallilankaraman K, Madesh M, Schafer AI, Durante W, Yang X, Wang H. Hyperhomocysteinemia impairs endothelium-derived hyperpolarizing factor-mediated vasorelaxation in transgenic cystathionine beta synthase-deficient mice. <i>Blood<\/i>, <b>118<\/b>, 1998\u20132006 (2011).","DOI":"10.1182\/blood-2011-01-333310"},{"key":"42","unstructured":"42) Wang XC, Sun WT, Yu CM, Pun SH, Underwood MJ, He GW, Yang Q. ER stress mediates homocysteine-induced endothelial dysfunction: modulation of IK<sub>Ca<\/sub> and SK<sub>Ca<\/sub> channels. <i>Atherosclerosis<\/i>, <b>242<\/b>, 191\u2013198 (2015)."},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Vallance P, Leone A, Calver A, Collier J, Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. <i>Lancet<\/i>, <b>339<\/b>, 572\u2013575 (1992).","DOI":"10.1016\/0140-6736(92)90865-Z"},{"key":"44","unstructured":"44) Dayoub H, Achan V, Adimoolam S, Jacobi J, Stuehlinger MC, Wang BY, Tsao PS, Kimoto M, Vallance P, Patterson AJ, Cooke JP. Dimethylarginine dimethylaminohydrolase regulates nitric oxide synthesis: genetic and physiological evidence. <i>Circulation<\/i>, <b>108<\/b>, 3042\u20133047 (2003)."},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Gross P, Massy ZA, Henaut L, Boudot C, Cagnard J, March C, Kamel S, Drueke TB, Six I. <i>para<\/i>-Cresyl sulfate acutely impairs vascular reactivity and induces vascular remodeling. <i>J. Cell. Physiol.<\/i>, <b>230<\/b>, 2927\u20132935 (2015).","DOI":"10.1002\/jcp.25018"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Six I, Gross P, Remond MC, Chillon JM, Poirot S, Drueke TB, Massy ZA. Deleterious vascular effects of indoxyl sulfate and reversal by oral adsorbent AST-120. <i>Atherosclerosis<\/i>, <b>243<\/b>, 248\u2013256 (2015).","DOI":"10.1016\/j.atherosclerosis.2015.09.019"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Matsumoto T, Takayanagi K, Kojima M, Taguchi K, Kobayashi T. Acute exposure to indoxyl sulfate impairs endothelium-dependent vasorelaxation in rat aorta. <i>Int. J. Mol. Sci.<\/i>, <b>20<\/b>, 338 (2019).","DOI":"10.3390\/ijms20020338"},{"key":"48","unstructured":"48) Ando M, Matsumoto T, Taguchi K, Kobayashi T. Poly(I:C) impairs NO donor-induced relaxation by overexposure to NO <i>via<\/i> the NF-kappa B\/iNOS pathway in rat superior mesenteric arteries. <i>Free Radic. Biol. Med.<\/i>, <b>112<\/b>, 553\u2013566 (2017)."},{"key":"49","doi-asserted-by":"crossref","unstructured":"49) Matsumoto T, Ishida K, Nakayama N, Taguchi K, Kobayashi T, Kamata K. Mechanisms underlying the losartan treatment-induced improvement in the endothelial dysfunction seen in mesenteric arteries from type 2 diabetic rats. <i>Pharmacol. Res.<\/i>, <b>62<\/b>, 271\u2013281 (2010).","DOI":"10.1016\/j.phrs.2010.03.003"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50) Matsumoto T, Noguchi E, Ishida K, Kobayashi T, Yamada N, Kamata K. Metformin normalizes endothelial function by suppressing vasoconstrictor prostanoids in mesenteric arteries from OLETF rats, a model of type 2 diabetes. <i>Am. J. Physiol. Heart Circ. Physiol.<\/i>, <b>295<\/b>, H1165\u2013H1176 (2008).","DOI":"10.1152\/ajpheart.00486.2008"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51) Matsumoto T, Kobayashi S, Ando M, Watanabe S, Iguchi M, Taguchi K, Kobayashi T. Impaired endothelium-derived hyperpolarization-type relaxation in superior mesenteric arteries isolated from female Otsuka Long-Evans Tokushima Fatty rats. <i>Eur. J. Pharmacol.<\/i>, <b>807<\/b>, 151\u2013158 (2017).","DOI":"10.1016\/j.ejphar.2017.03.062"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52) Matsumoto T, Kakami M, Noguchi E, Kobayashi T, Kamata K. Imbalance between endothelium-derived relaxing and contracting factors in mesenteric arteries from aged OLETF rats, a model of type 2 diabetes. <i>Am. J. Physiol. Heart Circ. Physiol.<\/i>, <b>293<\/b>, H1480\u2013H1490 (2007).","DOI":"10.1152\/ajpheart.00229.2007"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53) Adelibieke Y, Shimizu H, Saito S, Mironova R, Niwa T. Indoxyl sulfate counteracts endothelial effects of erythropoietin through suppression of Akt phosphorylation. <i>Circ. J.<\/i>, <b>77<\/b>, 1326\u20131336 (2013).","DOI":"10.1253\/circj.CJ-12-0884"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54) Yang K, Nie L, Huang Y, Zhang J, Xiao T, Guan X, Zhao J. Amelioration of uremic toxin indoxyl sulfate-induced endothelial cell dysfunction by Klotho protein. <i>Toxicol. Lett.<\/i>, <b>215<\/b>, 77\u201383 (2012).","DOI":"10.1016\/j.toxlet.2012.10.004"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55) Kharait S, Haddad DJ, Springer ML. Nitric oxide counters the inhibitor effects of uremic toxin indoxyl sulfate on endothelial cells by governing ERK MAP kinase and myosin light chain activation. <i>Biochem. Biophys. Res. Commun.<\/i>, <b>409<\/b>, 758\u2013763 (2011).","DOI":"10.1016\/j.bbrc.2011.05.084"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56) Yu M, Kim YJ, Kang DH. Indoxyl sulfate-induced endothelial dysfunction in patients with chronic kidney disease <i>via<\/i> an induction of oxidative stress. <i>Clin. J. Am. Soc. Nephrol.<\/i>, <b>6<\/b>, 30\u201339 (2011).","DOI":"10.2215\/CJN.05340610"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57) Tumur Z, Niwa T. Indoxyl sulfate inhibits nitric oxide production and cell viability by inducing oxidative stress in vascular endothelial cells. <i>Am. J. Nephrol.<\/i>, <b>29<\/b>, 551\u2013557 (2009).","DOI":"10.1159\/000191468"},{"key":"58","unstructured":"58) Adesso S, Magnus T, Cuzzocrea S, Campolo M, Rissiek B, Paciello O, Autore G, Pinto A, Marzocco S. Indoxyl sulfate affects glial function increasing oxidative stress and neuroinflammation in chronic kidney disease: interaction between astrocytes and microglia. <i>Front. Pharmacol.<\/i>, <b>8<\/b>, 370 (2017)."},{"key":"59","doi-asserted-by":"crossref","unstructured":"59) Li S, Cheng S, Sun Z, Mungun HK, Gong W, Yu J, Xia W, Zhang Y, Huang S, Zhang A, Jia Z. Indoxyl sulfate induces mesangial cell proliferation <i>via<\/i> the induction of COX-2. <i>Mediators Inflamm.<\/i>, <b>2016<\/b>, 5802973 (2016).","DOI":"10.1155\/2016\/5802973"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60) Knowles RG, Moncada S. Nitric oxide synthase in mammals. <i>Biochem. J.<\/i>, <b>298<\/b>, 249\u2013258 (1994).","DOI":"10.1042\/bj2980249"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61) Shen TY, Winter CA. Chemical and biological studies on indomethacin, sulindac and their analogs. <i>Adv. Drug Res.<\/i>, <b>12<\/b>, 90\u2013245 (1977).","DOI":"10.1016\/B978-0-12-013312-3.50007-8"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62) Grgic I, Kaistha BP, Hoyer J, Kohler R. Endothelial Ca+-activated K+ channels in normal and impaired EDHF-dilator responses\u2014relevance to cardiovascular pathologies and drug discovery. <i>Br. J. Pharmacol.<\/i>, <b>157<\/b>, 509\u2013526 (2009).","DOI":"10.1111\/j.1476-5381.2009.00132.x"},{"key":"63","unstructured":"63) Wulff H, Miller MJ, Hansel W, Grissmer S, Cahalan MD, Chandy KG. Desigh of a potent and selective inhibitor of the intermediate-conductance Ca<sup>2+<\/sup>-activated K<sup>+<\/sup> channel, <i>IKCa1<\/i>: a potent immunosuppressant. <i>Proc. Natl. Acad. Sci. U.S.A.<\/i>, <b>97<\/b>, 8151\u20138156 (2000)."},{"key":"64","doi-asserted-by":"crossref","unstructured":"64) Habermann E. Apamin. <i>Pharmacol. Ther.<\/i>, <b>25<\/b>, 255\u2013270 (1984).","DOI":"10.1016\/0163-7258(84)90046-9"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65) Montezano AC, Touyz RM. Reactive oxygen species and endothelial function\u2014role of nitric oxide synthase uncoupling and Nox family nicotinamide adenine dinucleotide phosphate oxidases. <i>Basic Clin. Pharmacol. Toxicol.<\/i>, <b>110<\/b>, 87\u201394 (2012).","DOI":"10.1111\/j.1742-7843.2011.00785.x"},{"key":"66","doi-asserted-by":"crossref","unstructured":"66) Su JB. Vascular endothelial dysfunction and pharmacological treatment. <i>World J. Cardiol.<\/i>, <b>7<\/b>, 719\u2013741 (2015).","DOI":"10.4330\/wjc.v7.i11.719"},{"key":"67","doi-asserted-by":"crossref","unstructured":"67) Stinghen AE, Chillon JM, Massy ZA, Boullier A. Differential effects of indoxyl sulfate and inorganic phosphate in a murine cerebral endothelial cell line (bEnd.3). <i>Toxins<\/i>, <b>6<\/b>, 1742\u20131760 (2014).","DOI":"10.3390\/toxins6061742"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68) Adachi T, Matsui R, Weisbrod RM, Najibi S, Cohen RA. Reduced sarco\/endoplasmic reticulum Ca<sup>2+<\/sup> uptake activity can account for the reduced response to NO, but not sodium nitroprusside, in hypercholosterolemic rabbit aorta. <i>Circulation<\/i>, <b>104<\/b>, 1040\u20131045 (2001).","DOI":"10.1161\/hc3501.093798"},{"key":"69","doi-asserted-by":"crossref","unstructured":"69) Tanaka Y, Koike K, Toro L. MaxiK channel roles in blood vessel relaxations induced by endothelium-derived relaxing factors and their molecular mechanisms. <i>J. Smooth Muscle Res.<\/i>, <b>40<\/b>, 125\u2013153 (2004).","DOI":"10.1540\/jsmr.40.125"},{"key":"70","unstructured":"70) Atoh K, Itoh H, Haneda M. Serum indoxyl sulfate levels in patients with diabetic nephropathy: relation to renal function. <i>Diabetes Res. Clin. Pract.<\/i>, <b>83<\/b>, 220\u2013226 (2009)."}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/42\/7\/42_b19-00177\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,6]],"date-time":"2019-07-06T03:21:47Z","timestamp":1562383307000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/42\/7\/42_b19-00177\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,1]]},"references-count":70,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b19-00177","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,1]]}}}